Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
65,095,000
-
Total 13F shares
-
187,480
-
Share change
-
+130,362
-
Total reported value
-
$2,947,108
-
Price per share
-
$15.68
-
Number of holders
-
13
-
Value change
-
+$2,045,377
-
Number of buys
-
13
Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) as of Q4 2025
As of 31 Dec 2025,
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
187,480 shares.
The largest 10 holders included
MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Allspring Global Investments Holdings, LLC, TEMA ETFS LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Brookwood Investment Group LLC, SG Americas Securities, LLC, Pallas Capital Advisors LLC, Mayflower Financial Advisors, LLC, NISA INVESTMENT ADVISORS, LLC, and GAMMA Investing LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.